Skip to main content
. 2022 Feb 16;60(2):e00161-21. doi: 10.1128/JCM.00161-21

TABLE 1.

Recommended donor selection criteria based on presently published guidance and protocolsa

Characteristic Consistently recommended Occasionally recommended Case-by-case basis Recently recommended
Relationship to patient
 Intimate, long-time partner (25, 26, 51, 52)
 Unknown to patient (26, 53)
Inclusion criteria
 Age > 18 (25, 26, 34, 52, 53)
 Children with parental consent and child assent (25, 52)
 Negative screening questionnaire similar to those given to potential blood donors (23, 25, 26, 34, 5153)
Exclusion criteria
 Risk factors for transmittable diseases (e.g., new sexual contact in last six mo, recent needle stick accident, recent transfusion, i.v. drug use, risk for variant Creutzfeldt-Jakob disease, sex for drugs or money, homosexuality, or tattoos) (23, 24, 26, 34, 53)
 Travel to tropical area in last 3 mo (23, 25, 26, 34, 51, 53)
 Known history of tropical infection (23)
 Employment in clinical work (23, 34, 53)
 Use of antibiotics in the 3 mo prior to donation (23, 25, 26, 34, 5153)
 Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 hours (23, 34, 51, 53)
 Household contacts with active gastrointestinal infection (26)
 Abnormal blood or stool test result suggestive of active/current disease (23, 25, 26, 34, 5153)
 Any gastrointestinal illness (inflammatory bowel disease, irritable bowel syndrome, gastrointestinal malignancies, or major gastrointestinal surgery) or complaints (23, 25, 26, 34, 5153)
 Family history of intestinal cancer or inflammatory bowel disease  (23, 34, 52)
 Diet (51)
 History of autoimmune or atopic illness or ongoing immune modulating therapy (23, 25, 26, 34, 51, 53)
 History of chronic pain syndromes (fibromyalgia, chronic fatigue) or neurologic or neurodevelopmental disorders (25, 26, 34, 51, 53)
 History of psychiatric conditions (25, 34)
 Metabolic syndrome, obesity (BMI of >30), moderate to severe undernutrition (23, 25, 26, 34, 51, 53)
 History of malignancy/receipt of chemotherapy (23, 25, 26, 34, 51, 53)
a

Consistently recommended, recommended in >4 guidance/protocols; occasionally recommended, recommended in some but not >4 guidance/protocols; case-by-case basis, case-by-case consideration of screening is suggested; recently recommended, recently recommended in response to reported safety concerns. i.v., intravenous; BMI, body mass index.